Current Appointments & Affiliations
Associate Professor of Medicine
·
2024 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Member of the Duke Cancer Institute
·
2016 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia.
Journal Article Hemasphere · December 2025 Full text Link to item CiteRefitting fitness in CLL.
Journal Article Blood · November 13, 2025 Full text Link to item CitePrognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.
Journal Article Am J Hematol · September 2025 Full text Link to item CiteRecent Grants
The MAVRiC Study: A Phase II Study of Disease Risk Mutation-guided Finite Duration Acalabrutinib plus Venetoclax for Relapse in CLL/SLL after First-line Finite covalent BTKi plus BCL2i combination, with or without Obinutuzumab
Clinical TrialPrincipal Investigator · Awarded by AstraZeneca Pharmaceuticals, LP · 2025 - 2031A Phase 1b Study of Oral AS-1763 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Clinical TrialPrincipal Investigator · Awarded by Carna Biosciences, Inc. · 2025 - 2030A Phase 1 Study of ABBV-453 in Adult Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Clinical TrialPrincipal Investigator · Awarded by AbbVie Inc. · 2025 - 2030View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2007
M.D.